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Abstract
Background: Metabolic syndrome (MS) comprises a set of conditions that are risk factors for cardiovascular
diseases and diabetes. Numerous epidemiological studies on MS have been conducted, but there has not been a
systematic analysis of the prevalence of MS in the Chinese population. Therefore, the aim of this study was to
estimate the pooled prevalence of MS among subjects in Mainland China.
Methods: We performed a systematic review by searching both English and Chinese literature databases. Random
or fixed effects models were used to summarize the prevalence of MS according to statistical tests for
heterogeneity. Subgroup, sensitivity, and meta-regression analyses were performed to address heterogeneity.
Publication bias was evaluated using Egger’s test.
Results: Thirty-five papers were included in the meta-analysis, with a total population of 226,653 Chinese subjects.
Among subjects aged 15 years and older, the pooled prevalence was 24.5 % (95 % CI: 22.0–26.9 %). By sex, the
prevalences were 19.2 % (95 % CI: 16.9–21.6 %) in males and 27.0 % (95 % CI: 23.5–30.5 %) in females. The pooled
prevalence of MS increased with age (15–39 years: 13.9 %; 40–59 years: 26.4 %; and ≥60 years: 32.4 %). Individuals
living in urban areas (24.9 %, 95 % CI: 18.5–31.3 %) were more likely to suffer from MS than those living in rural
areas (19.2 %, 95 % CI: 14.8–23.7 %). Hypertension was the most prevalent component of MS in males (52.8 %),
while the most prevalent component of MS for females was central obesity (46.1 %).
Conclusions: Our systematic review suggested a high prevalence of MS among subjects in Mainland China,
indicating that MS is a serious public health problem. Therefore, more attention should be paid to the prevention
and control of MS.
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Background
Metabolic syndrome (MS) is characterized by a cluster
of metabolic disorders, such as high blood pressure,
hyperglycaemia, central adiposity, and dyslipidemia [1,
2]. MS is considered to be risk factor for coronary heart
disease, other cardiovascular diseases (CVD), stroke, and
type 2 diabetes mellitus [3, 4]. The prevalence of MS is
increasing in both developed and developing countries
and has become a serious public health problem world-
wide [5–8].
China is the world’s largest developing country and is
experiencing an epidemic of MS [9]. The Nantong MS
Study conducted between 2007 and 2008 in south China
showed that the prevalence of MS was 15.2 % [10]. A
study in north China revealed that the prevalence of MS
was 21.6 % in males and 34.3 % in females [11]. The
prevalence may vary due to the diverse populations of
different regions, cultural behaviours, lifestyle habits,
and the use of different diagnosis criteria [2, 9, 12].
* Correspondence: ; ywliu@jlu.edu.cn
†Equal contributors
6Department of Cardiovascular Center, First Hospital of Jilin University,
Changchun City, Jilin Province, China
1Department of Epidemiology and Biostatistics, School of Public Health, Jilin
University, Changchun City, Jilin Province, China
Full list of author information is available at the end of the article
© 2016 Li et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Li et al. BMC Public Health  (2016) 16:296 
DOI 10.1186/s12889-016-2870-y
Although a number of epidemiological studies on MS
were conducted in the Chinese population in recent
years, very little nationwide information exists on the
prevalence of MS. A nationwide estimate of MS preva-
lence in the China population would contribute to the
planning and implementation of relevant public health
strategies. Therefore, we performed a systematic review
of epidemiological studies of MS to estimate the preva-
lence of MS among subjects in Mainland China.
Methods
Search strategy
We searched for epidemiological studies on MS from the
several electronic databases, including Medline, Embase,
the China National Knowledge Infrastructure (CNKI), and
the Wanfang and Chongqing VIP. The following search
strategy was used: (‘Metabolic syndrome’ OR ‘MS’ OR
‘MetSyn’) AND (‘prevalence’ OR ‘epidemi*’) AND (‘Chin-
ese’ OR ‘China’ OR ‘Mainland’). All studies published from
January 1, 2005 to April 30, 2015 were searched. Unpub-
lished studies were not retrieved. The search language was
limited to English and Chinese.
Inclusion and exclusion criteria
To satisfy the analysis requirements and reduce selection
deviation, the selected studies were required to meet the
following criteria: 1) a population-based study conducted
in Mainland China; 2) a cross-sectional study or data; 3)
sufficient information of sample size and crude preva-
lence of MS; 4) a sample size > 500; 5) participants aged
15 years and older; and 6) the use MS diagnostic criteria
proposed by the International Diabetes Federation (IDF)
in 2005 [13]. According to the IDF criteria, the partici-
pants were classified as having MS if they had central
obesity (waist circumference ≥ 90 cm for men and ≥ 80 cm
for females) plus any two of the following four abnormal-
ities: a) Hypertension: systolic blood pressure ≥ 130 mmHg,
diastolic blood pressure ≥ 85 mmHg, or treatment of pre-
viously diagnosed hypertension; b) Hypertriglyceridemia:
≥ 1.7 mmol/L triglycerides or specific medical treatment
for lipid abnormalities; c) Hypo-HDL-cholesterol: <
1.03 mmol/L HDL cholesterol for men or < 1.29 mmol/L
for females; and d) Raised fasting glucose: overnight ≥
5.6 mmol/L plasma glucose or previously diagnosed dia-
betes. We excluded studies that investigated specific occu-
pations, volunteers, and hospital-based populations. If
there were multiple articles based on the same population,
only the study that reported the most detailed data was
included.
Data extraction and quality assessment
All searched articles from different electronic databases
were combined in Endnote, and duplicates were removed.
Two researchers independently screened the titles and
abstracts and reviewed the full text of the eligible citations.
If they were in disagreement, a third reviewer made the
final decision. For each included study, two researchers in-
dependently extracted the following information: general
information (e.g., first author, title, journal, and publication
year); study characteristics (including study period, study
area, study design, sample source, sample selection method,
diagnostic criteria, and sample size); and all possible partici-
pant information(e.g., sex ratio, age, prevalence of MS, age-
specific prevalence of MS, the prevalence of central obesity,
hypertension, raised fasting glucose, hypertriglyceridaemia,
and low high-density liprotein (HDL) cholesterol). Two re-
searchers independently assessed the quality of each in-
cluded study using observational study criteria that were
recommended by the Agency of Healthcare Research and
Quality [14]. Only when two reviewers agreed was the
study included in the meta-analysis. The retained articles
were required to have a quality score of at least 6 of 11.
Statistical analysis
We used a systematic analysis approach to calculate the
pooled prevalence of MS from all eligible studies. A ran-
dom or fixed effects model was selected to summarize
the prevalence of MS, using statistical tests for hetero-
geneity. Heterogeneity among studies was assessed using
Cochran’s Q test and I2 statistic, which shows the per-
centage of variation across studies (with values of 25, 50,
and 75 % indicating low, moderate, and high degrees of
heterogeneity, respectively) [15, 16]. If the data showed
low or moderate heterogeneity (I2 < 50 %), a fixed-effect
model was used; otherwise, a random-effect model was
used. Subgroup analyses by geographic region, age, sex,
and the year of screening were performed to address
heterogeneity. Additionally, a meta-regression was con-
ducted to explore potential sources of heterogeneity.
Variables such as the year of publication, year of screen-
ing, response rate, geographic area (e.g., northern vs.
southern China), sex ratio (males vs. females), sample
size, age range, and quality score were used to perform
the meta-regression. Additionally, sensitivity analysis
(i.e., recalculating the pooled estimate by omitting stud-
ies with low scores) was performed to assess the influ-
ence of any particular study on the pooled estimate.
Publication bias was evaluated using Egger’s Test, and
independent t-tests were performed as appropriate. The
significance level was set at a P value of less than 0.05.
All statistical analyses were performed using Stata ver-
sion 12.0 (College Station, Texas) and SPSS version 20.0
(SPSS Inc., Chicago, USA).
Results
Search results and included subjects
A total of 1405 citations were searched. Of these, 510 du-
plicates were removed, and 358 citations were excluded
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after reading the titles and abstracts. Five hundred thirty-
seven articles were further excluded after reviewing the
full texts. In total, 35 eligible studies were included in the
meta-analysis, which involved a total of 226,653 subjects.
The flow diagram of the search process is shown in Fig. 1.
Among the 35 published papers, 22 were written in
Chinese and 13 were written in English. All of the in-
cluded studies were cross-sectional surveys. Thirty-one
studies reported data on males (n = 94,241) and 32 stud-
ies reported data on females (n = 127,079). Sixteen and
17 studies were conducted on the populations of south
and north China, respectively, and two nationwide studies
were conducted. Table 1 shows the detailed characteristics
of the 35 studies selected. On a quality assessment scale,
seven studies scored 6, and 28 articles scored between 6
and 10. Additional file 1 shows the score of each study.
Prevalence of metabolic syndrome
The pooled prevalence of MS among Chinese subjects
was 24.5 % (95 % CI: 22.0–26.9 %), with a high-level
between-study heterogeneity (I2 = 99.5 %, P < 0.0001).
Table 2 demonstrates the pooled prevalence of all sub-
groups stratified by sex, geographic area, study period,
and age range. The pooled prevalence in males (19.2 %,
95 % CI: 16.9–21.6 %, Fig. 2) was lower than that of fe-
males (27.0 %, 95 % CI: 23.5–30.5 %, Fig. 3). The t-tests
showed that the prevalence of MS was significantly dif-
ferent between males and females (P = 0.002). The preva-
lences of MS in the populations of north and south
China were similar (24.4 and 24.6 %, respectively). The
pooled prevalence of MS in the population living in rural
areas (19.2 %, 95 % CI: 14.8–23.7 %) was lower than was
observed in urban areas (24.9 %, 95 % CI: 18.5–31.3 %).
The pooled prevalence of MS increased with time. The
pooled prevalence was 23.8 % (95 % CI: 17.7–29.9 %)
during 2000–2005, increasing to 22.3 % (95 % CI: 20.3–
24.3 %) during 2005–2010 and 27.0 % (95 % CI: 22.2–
31.8 %) during 2010–2015. Additionally, the summarized
prevalence of MS increased with age. The pooled preva-
lences of MS for specific age ranges were 13.9 % (95 %
CI: 9.5–18.2 %) for subjects aged 15–39 years, 26.4 %
(95 % CI: 20.5–32.3 %) for subjects aged 40–59 years,
Fig. 1 Flow diagram of studies included in the systematic review
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and 32.4 % (95 % CI: 26.1–38.8 %) for subjects
aged ≥ 60 years. The prevalence of MS increased with
age in males, peaking in the 40–59 year age group
and decreasing thereafter. The prevalence of MS also
increased with age in females, peaking in the ≥ 60 years
group.
Prevalence of components of metabolic syndrome
In terms of the different components of MS, the pooled
prevalence estimates of central obesity, hypertension,
high fasting plasma glucose, hypertriglyceridaemia, and
low HDL cholesterol in males were 33.4, 52.8, 31.5, 32.9,
and 27.4 %, respectively. For females, these estimates
Table 1 Characteristic of studies on the prevalence of metabolic syndrome










1 Zhang YH et al. a[37] 2014 2008 Beijing Northern ≥18y 0.94 161 724 22.2 7
Zhang YH et al. b[37] 2014 2011 Beijing Northern ≥18y 0.67 279 864 32.3 7
2 Cao YL et al. [38] 2015 2013 Hunan Southern ≥18y 1.16 826 3108 26.58 7
3 Chen QY et al. [39] 2007 2003–2005 Guangxi Southern ≥15y 1.28 3582 27,240 13.15 6
4 Li H et al. [40] 2013 2011 Guizhou Southern 40–79y 0.37 4063 10,016 40.57 7
5 Fu SY et al. [41] 2010 2007 Heilongjiang Northern 35–91y 0.802 1472 5984 24.6 8
6 Tao R et al. [42] 2015 2010 Jiangsu Southern 18–95y 0.901 2472 8380 29.5 8
7 Xu DM et al. [43] 2010 2007–2008 Henan Northern 18–88y 0 89 579 15.3 7
8 Lu W et al. [44] 2006 2002–2003 Shanghai Southern 15–74y 0.745 2509 14,327 17.51 10
9 Hu Y et al. [45] 2008 2007 Liaoning Northern 65–94y 1.96 633 2730 23.19 7
10 Wang WC et al. [46] 2014 2011 Hebei Northern ≥45y 0.543 307 1447 21.2 8
11 Du YH et al. [47] 2007 2005–2006 Shanxi Northern 20–93y 0.488 979 3869 25.3 9
12 Yu H et al. [48] 2012 2010 Tianjin Northern 30–60y 1.02 546 2993 18.24 8
13 Yu L et al. [49] 2008 2003–2004 Neimonggu Northern ≥20y 0.693 530 2536 20.9 8
14 Zhang SQ et al. [50] 2007 2002 Zhejiang Southern ≥50y 0.672 288 1187 24.26 6
15 Zhao FC et al. [51] 2009 2007 Xinjiang Northern 20–74y 0.69 823 3293 24.99 7
16 Li SJ et al. [52] 2012 2010 Zhejiang Southern ≥18y 0.775 179 600 29.83 7
17 Deng M et al. [53] 2014 2011–2012 Chongqing Southern ≥35y 0.713 1092 5384 20.28 6
18 Ye QY et al. [54] 2012 2010 Zhejiang Southern ≥18y 0.88 339 1248 27.16 7
19 Ta JGL et al. [55] 2013 2010 Xinjiang Northern ≥20y 0.457 817 2138 38.2 7
20 Li CH et al. [56] 2012 2010 Xinjiang Northern ≥18y 0.97 730 3442 21.2 8
21 Li YQ et al. [57] 2014 2012 Guangdong Southern 18–75y 0.595 383 1724 22.22 6
22 Zhao Y et al. [33] 2010 2008–2009 Ningxia Northern ≥25y null 355 1612 22 8
23 Sun M et al. [58] 2014 2011 Jiangsu Southern ≥40y 0.6 2973 7489 39.7 9
24 Lao XQ et al. [9] 2014 2010 Guangdong Southern ≥20y 0.82 872 3561 24.5 8
25 Yu M et al. [59] 2014 2009 Zhejiang Southern 19–79y 1 1242 8169 15.2 6
26 He Yao et al. [60] 2006 2001–2002 Beijing Northern 60–95y 0.67 1081 2334 46.3 8
27 Zhou HC et al. [61] 2014 2007–2008 14 provinces National ≥20y 0.66 11,244 45,157 24.9 8
28 Xi B et al. [34] 2013 2009 9 provinces National ≥18y 0.871 1767 7488 23.6 7
29 Peng X et al. [62] 2009 2007 Hunan Southern ≥18y 0.99 260 1709 15.2 7
30 Cai H et al. [2] 2012 2007–2008 Jiangsu Southern 18–74y 0 2965 13,505 22 6
31 Zhao J et al. [11] 2011 2006 Shandong Northern 35–74y 0.688 1082 5355 20.2 7
32 Tan XU et al. [63] 2009 2002–2003 Neimonggu Northern ≥20y 0.693 530 2536 20.9 7
33 Li G et al. [64] 2010 2005 Beijing Northern ≥18y 0.652 4587 16,442 27.9 6
34 Zhao YL et al. [65] 2014 2010 Shanxi Northern 18–80y 0.529 407 2990 13.6 8
35 Xu F et al. [66] 2011 2009–2010 Jiangsu Southern 18–74y 0.878 1213 4493 27 7
Study[37] has two parts; athe screening year of one part is 2008, bthe screening year of the other part is 2011
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Table 2 Prevalence of MS according to a different category
Category Subgroup NO.of study Prevalence (95 % CI)(%) Sample I2(%) P P(Egger’s Test)
Total 36 24.5(22.0–26.9) 226,653 99.5 <0.001 0.072
Geographic region Northern 17 24.4(21.4–27.3) 61,868 98.7 <0.001 0.976
Southern 16 24.6(20.2–29.1) 112,140 99.7 <0.001 0.036
Urban 7 24.9(18.5–31.3) 24,560 99.3 <0.001 0.060
Rural 16 19.2(14.8–23.7) 53,268 99.5 <0.001 0.048
Sex Male 31 19.2(16.9–21.6) 94,241 98.9 <0.001 0.150
Female 32 27.0(23.5–30.5) 127,079 99.8 <0.001 0.141
Screening year 2000–2005 6 23.8(17.7–29.9) 50,160 99.6 <0.001 0.051
2005–2010 15 22.3(20.3–24.3) 121,109 98.4 <0.001 0.322
2010–2015 15 27.0(22.2–31.8) 55,384 99.4 <0.001 0.571
Age-specific group(y) 15–39 10 13.9(9.5–18.2) 20,273 98.8 <0.001 0.017
40–59 12 26.4(20.5–32.3) 38,484 99.4 <0.001 0.258
≥60 12 32.4(26.1–38.8) 18,652 98.8 <0.001 0.955
Male 15–39 5 14.9(6.8–23.0) 8585 99.0 <0.001 0.100
40–59 7 23.4(16.3–30.5) 14,845 98.8 <0.001 0.279
≥60 7 23.0(18.0–28.0) 7850 96.2 <0.001 0.292
Female 15–39 5 9.5(5.3–13.7) 9536 98.2 <0.001 0.069
40–59 7 27.2(19.3–35.2) 19,586 99.3 <0.001 0.550
≥60 7 42.9(34.5–51.3) 8800 98.4 <0.001 0.273
Fig. 2 Forest plot of the studies of males
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were 46.1, 40.1, 26.3, 27.7, and 40.4 %, respectively.
The prevalence of hypertension in males was signifi-
cantly higher than in females (P = 0.049). Table 3
shows the pooled prevalences of different the com-
ponents of MS.
Sensitivity analysis and meta-regression
Seven citations had a quality score of 6, the lowest
among the included studies. In the sensitivity analysis,
we noticed a slight change in the pooled MS prevalence
estimate (from 24.5 to 25.4 %) when we omitted these
seven studies. Egger’s linear regression test (P = 0.072)
suggested no significant publication bias.
A high level of heterogeneity between studies and sub-
groups was observed (P < 0.001, I2 = 96.2–99.8 %). We
performed a meta-regression to take this heterogeneity
into account. In the univariate meta-regression and mul-
tivariable analyses, only the variable of age was signifi-
cantly associated with heterogeneity (P = 0.01, P = 0.02,
respectively) (Table 4).
Fig. 3 Forest plot of the studies of females
Table 3 Prevalence of different components of MS
Types Sex NO. of study Sample Pooled
prevalence(95 % CI)(%)
Median(%) Minimum(%) Maximum(%) t P
Central obesity Male 14 38,434 33.4(25.3–41.5) 26 18 68.8 −2.034 0.052
Female 15 44,646 46.1(37.0–55.2) 47.2 6.8 77.5
Hypertension Male 14 38,434 52.8(45.3–60.4) 30.3 52 79 2.066 0.049
Female 15 44,646 40.1(32.2–48.0) 41.3 15 75.9
High Fasting Plasma Glucose Male 14 38,434 31.5(25.3–37.8) 31 10.2 52.3 0.981 0.335
Female 15 44,646 26.3(19.0–33.6) 24 3.4 52.5
Hypertriglyceridaemia (TG) Male 14 38,434 32.9(27.5–38.3) 32.9 11.6 53.8 1.189 0.245
Female 15 44,646 27.7(22.0–33.4) 27.1 7.3 56.3
Low HDL-C Male 14 38,434 27.4(22.2–32.5) 27.2 5 55.5 −1.991 0.057
Female 15 44,646 40.4(30.6–50.2) 36.3 1.4 70.4
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Discussion
Our systematic review of observational studies con-
ducted in the last decade included 35 studies that in-
volved a total of 226,653 participants in Mainland China
and covered most regions of the country. The definitions
of IDF and the US National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP ATP III) are
widely used in China [9]. The IDF criteria recognize and
emphasize differences in waist circumference for Chin-
ese populations [17]. Thus, the IDF criteria were adopted
in our meta-analysis.
Our meta-analysis revealed that the pooled estimate of
MS prevalence among subjects in Mainland China was
24.5 %. This estimate was higher than the prevalence of
16.5 % observed in China in 2000 and approached the
worldwide prevalence of 20–25 % [5, 18]. The preva-
lence of MS has recently increased in developing coun-
tries. Several studies have reported a high prevalence of
MS in Malaysia (27.5 %), India (28.2 %), Philippines
(19.7 %), Nigeria (28.1 %), Brazil (29.6 %), Turkey
(44.0 %), and Iran (36.9 %) [19–25]. As the largest devel-
oping country, China is experiencing an emerging epi-
demic of MS, which might be related to rapid economic
development and urbanization [9]. Rapid industrialization
and urbanization can lead to accelerating changes in life-
style and nutrition. The prevalences of obesity and over-
weight have increased dramatically in China due to the
changes in the lifestyle of the population, and some of
these changes are independent factors that contribute to
MS. Data from the China Health and Nutrition Survey
shows that the age-adjusted prevalence of obesity in-
creased from 3.75 % in 1991 to 11.3 % in 2011, and the
prevalence of overweight was up to 42.3 % in 2011 [26]. In
addition, another major factor driving MS growth is likely
the ageing of the Chinese population. Studies have shown
an increased prevalence of MS with age [19, 27]. Data
from the National Bureau of Statistics in 2011 showed that
people aged 60 and older accounted for 13.26 % of the
Chinese population, with those 65 years and older repre-
senting 8.87 % of the population. These data show that
China is now an ageing society [28].
Our systematic review showed that MS was more
common in females than in males (27.0 vs. 19.2 %), a re-
sult that is in line with previous findings [19, 27, 29].
Menopause may have effects on the high prevalence of
MS among females. Post-menopausal status is associated
with an increased risk of central obesity and insulin re-
sistance [30]. Our meta-analysis discovered that central
obesity was the most prevalent component of MS in fe-
males. Moreover, a relationship was observed between
the prevalence of MS and age in both males and females,
which is consistent with other studies [31, 32]. The in-
creased prevalence of MS with age can be attributed to
similar age-related trends in all components of MS [9,
33]. Additionally, individuals living in urban areas were
more likely to suffer from MS than those living in rural
areas. Unhealthy lifestyles in urban area, including de-
creased physical activity, excessive intake of animal fat
and salt, and low intake of fruits and vegetables might
explain the difference in MS prevalence between the two
regions [34].
There is an emerging MS epidemic in Mainland
China, and it has become a serious public health prob-
lem. MS increases the risk for morbidity and mortality
Table 4 Results of meta-regression for the prevalence of metabolic syndrome
Covariate Meta-regression coefficient 95 % confidence interval P value Variance explained (%)
Univariate analyses
Sex ratio(male vs. female) 0.846 0.6195–1.155 0.283 1.83
Area(northern vs. southern) 1.0104 0.8486–1.2031 0.904 −3.14
Quality score 1.0044 0.9370–1.1641 0.421 −0.96
Year of screening 1.1046 0.9617–1.2687 0.153 3.62
Sample size, continuous 1.0000 0.9999–1.0001 0.519 −1.65
Age group(15 ~ =1, 40 ~ =2, 60 ~ =3) 1.2625 1.0615–1.5017 0.010 17.63
Year of publication 1.0988 0.8671–1.3924 0.424 −0.90
Multivariable analyses 26.74
Sex ratio(male vs. female) −0.2331 −0.5318–0.6585 0.121
Area(northern vs. southern) 0.0095 −0.1543–0.1734 0.906
Quality score 0.0285 −0.0746–0.1315 0.576
Year of screening 0.0906 −0.9722–0.2785 0.331
Sample size, continuous 3.28e’-7 −0.0000–0.0001 0.952
Age group(15 ~ =1, 40 ~ =2, 60 ~ =3) 0.3035 0.1187–0.4884 0.002
Year of publication 0.9168 −0.2391–0.4225 0.574
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of cardiovascular disease and is associated with an in-
creased risk of diabetes [5]. Studies have shown that the
components of the syndrome tend to aggregate in indi-
viduals, and this clustering effect is associated with a
worse prognosis than exhibiting a single component [35,
36]. Our results showed that MS was highly prevalent,
especially in female, elderly participants and those living
in urban areas. These data may be useful for the Chinese
government in its formulation of guidelines to prevent,
screen for and treat MS.
Strengths and limitations
The overall quality of the studies included in our system-
atic review was good; therefore, the sensitivity analysis did
not show major differences in the meta-analysis results
when studies with the lowest quality scores were omitted.
Our meta-analysis included 35 published studies with a
large sample size. Nevertheless, our study had some limi-
tations. First, we used the IDF criteria as our diagnosis cri-
teria, and studies based on other diagnosis criteria were
not included in our meta-analysis. Second, although most
of the included studies had a large sample size that could
generate an accurate estimation, the overall analysis re-
vealed a high heterogeneity. Additionally, meta-regression
and subgroup analyses did not indicate enough factors to
explain the observed heterogeneity. We propose that
other factors, such as cigarette smoking, alcohol con-
sumption, stress, and physical inactivity may influence MS
heterogeneity. Because of the limited information on these
aspects, we could not perform further analyses. Third, the
distribution of healthcare resources in Mainland China is
unbalanced, with more economically developed areas hav-
ing better access to health care facilities. This factor may
have contributed to more diagnoses and, therefore, a
higher reported prevalence in certain studies of different
regions in Mainland China.
Conclusion
To the best of our knowledge, this was the first systematic
review to estimate the pooled prevalence of MS among
subjects in Mainland China. Our systematic review indi-
cates a high prevalence of MS among subjects in Main-
land China. Information on how MS and its components
are distributed could provide a great deal of insight into
MS and assist in the planning and implementation of fu-
ture prevention and control programmes.
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